Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37824996

about

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia Immune reconstitution in chronic lymphocytic leukemia Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia.Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.

P2860

Q24594920-D1E1964B-223F-4830-A51C-474219ABF2E8 Q26865561-6A28A825-ACF5-47E2-B2C7-8665D4F10C36 Q35114910-9773EA53-2FBA-49EE-A964-E16C23608AA0 Q35450520-A8E373FF-8DF9-4424-A8FA-C1119654589C Q36382751-1C65F931-86C2-4408-BA7E-F9D293133B4F Q36416452-10CF6FB1-EF57-43A6-A50F-32B7DFB0F346 Q36549460-8684A33F-968A-4037-9CD4-4954004A31B4

P2860

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37824996

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@en

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@nl

type

label

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@en

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@nl

prefLabel

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@en

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@nl

P1433

Q37824996-5F19ACF8-20B4-44B2-A1C1-38A30597F9E1

P1476

Q37824996-DED0A57A-82B2-4677-9C01-657FA57F4594

P2093

Q37824996-D0DCB3B0-519B-4C9A-9FF0-B2BF0B34161F

P2860

Q37824996-0C248134-7222-4E26-B187-42FBC128E7BC

Q37824996-0E675651-7469-4193-B527-51314D5EE0D5

Q37824996-12375AFE-40DD-482F-A9AE-69B193F678A2

Q37824996-1472390E-A7EB-4E35-9549-D48AA7C02BAC

Q37824996-19CE6923-4784-486F-A813-D5B22A3B943F

Q37824996-21692265-9B5F-4E9D-BECC-319455A058E3

Q37824996-2643D4DC-10A8-4A1E-8468-14320DAE2E04

Q37824996-27C4215C-2A1E-4161-A718-C65D8486B7BB

Q37824996-2AE8F5B5-5C11-444C-9731-3BF6E0F2C729

Q37824996-2BC7F158-5233-4D64-B586-B74DBD9DC70A

P304

Q37824996-275189C8-D6FB-4A7D-BBAD-94F77BEE19C3

P31

Q37824996-FF069ED4-FD4B-4201-93FC-EBEC718F7480

Q37824996-fbf0abfd-07d5-41e1-9f01-438e420465f4

P356

Q37824996-BF071620-33C8-4BFD-BCCE-591EE9FA432B

P433

Q37824996-33F24B7E-47B9-4874-9220-3A514E566C13

P478

Q37824996-3DE5A260-8F92-4FF8-967B-648AEB8C28E8

P50

Q37824996-013540D0-D531-4C3F-9376-4DCCFF29E9B4

Q37824996-412C8FCD-CEF4-4800-8D5E-09926843E8E9

P577

Q37824996-7FA82F31-7DE1-4488-8349-C94EFDD2A9D8

P5875

Q37824996-EDFF550B-5754-4BD5-9F00-3BAA72FA44DE

P698

Q37824996-23E6C061-9801-4A5D-8379-B542CB0AFF38

P921

Q37824996-4F404885-9372-4D01-9237-4A686D4BBDAF

Q37824996-56775378-6F72-4B6A-BC59-DC71921B7034

P932

Q37824996-8F241ABA-D8C2-427C-850B-9D25E18A1F93

P356

J.BBMT.2010.10.011

P1433

Biology of Blood and Marrow Transplantation

P1476

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

@en

P2093

John G Gribben

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Tregs and rethinking cancer immunotherapy.

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

Current status of therapeutic vaccines for non-Hodgkin's lymphoma.

P304

S63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.10.011

http://www.w3.org/2001/XMLSchema#string

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

David G. Maloney

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49718395

http://www.w3.org/2001/XMLSchema#string

P698

21195313

http://www.w3.org/2001/XMLSchema#string

P921

P932

3392079

http://www.w3.org/2001/XMLSchema#string